Study Evaluating The Efficacy And Safety Of SBI-087 In Seropositive Subjects With Active Rheumatoid Arthritis

Update Il y a 4 ans
Reference: NCT01008852

Woman and Man

Extract

This study is designed to evaluate the safety and efficacy of a dose and dosage regimen of SBI-087 in seropositive patients with active Rheumatoid Arthritis, who are on a stable dose of methotrexate.


Inclusion criteria

  • active rheumatoid arthritis


Links